JACCS Co Ltd
TSE:8584
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
JACCS Co Ltd
Cash & Cash Equivalents
JACCS Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JACCS Co Ltd
TSE:8584
|
Cash & Cash Equivalents
ÂĄ187.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
|
Marui Group Co Ltd
TSE:8252
|
Cash & Cash Equivalents
ÂĄ64.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
Credit Saison Co Ltd
TSE:8253
|
Cash & Cash Equivalents
ÂĄ108.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Aiful Corp
TSE:8515
|
Cash & Cash Equivalents
ÂĄ56.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-2%
|
|
A
|
Acom Co Ltd
TSE:8572
|
Cash & Cash Equivalents
ÂĄ73.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
Orient Corp
TSE:8585
|
Cash & Cash Equivalents
ÂĄ479.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
16%
|
See Also
What is JACCS Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
187.6B
JPY
Based on the financial report for Mar 31, 2024, JACCS Co Ltd's Cash & Cash Equivalents amounts to 187.6B JPY.
What is JACCS Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
10%
Over the last year, the Cash & Cash Equivalents growth was 16%. The average annual Cash & Cash Equivalents growth rates for JACCS Co Ltd have been 19% over the past three years , 16% over the past five years , and 10% over the past ten years .